Nextar's proprietary Brain Targeted Liposomes (BTLs) platform, can facilitate targeted delivery of versatile drugs across the BBB and into the brain. The innovative drug delivery platform is a combination of a liposomal vehicle with the unique Targeter complex that allows BBB permeation and brain-specific delivery of versatile therapeutic agents.